Division of Endocrinology and Metabolism, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Arizona State University, Barrett, The Honors College, Tempe, AZ, USA.
Int J Obes (Lond). 2021 Jun;45(6):1331-1341. doi: 10.1038/s41366-021-00801-w. Epub 2021 Mar 22.
Long chain omega-3 polyunsaturated fatty acids (ω-3PUFA) supplementation in animal models of diet-induced obesity has consistently shown to improve insulin sensitivity. The same is not always reported in human studies with insulin resistant (IR) subjects with obesity.
We studied whether high-dose ω-3PUFA supplementation for 3 months improves insulin sensitivity and adipose tissue (AT) inflammation in IR subjects with obesity.
Thirteen subjects (BMI = 39.3 ± 1.6 kg/m) underwent 80 mU/m·min euglycemic-hyperinsulinemic clamp with subcutaneous (Sc) AT biopsy before and after 3 months of ω-3PUFA (DHA and EPA, 4 g/daily) supplementation. Cytoadipokine plasma profiles were assessed before and after ω-3PUFA. AT-specific inflammatory gene expression was evaluated on Sc fat biopsies. Microarray analysis was performed on the fat biopsies collected during the program.
Palmitic and stearic acid plasma levels were significantly reduced (P < 0.05) after ω-3PUFA. Gene expression of pro-inflammatory markers and adipokines were improved after ω-3PUFA (P < 0.05). Systemic inflammation was decreased after ω-3PUFA, as shown by cytokine assessment (P < 0.05). These changes were associated with a 25% increase in insulin-stimulated glucose disposal (4.7 ± 0.6 mg/kg ffm•min vs. 5.9 ± 0.9 mg/kg ffm•min) despite no change in body weight. Microarray analysis identified 53 probe sets significantly altered post- ω-3PUFA, with Apolipoprotein E (APOE) being one of the most upregulated genes.
High dose of long chain ω-3PUFA supplementation modulates significant changes in plasma fatty acid profile, AT, and systemic inflammation. These findings are associated with significant improvement of insulin-stimulated glucose disposal. Unbiased microarray analysis of Sc fat biopsy identified APOE as among the most differentially regulated gene after ω-3PUFA supplementation. We speculate that ω-3PUFA increases macrophage-derived APOE mRNA levels with anti-inflammatory properties.
在饮食诱导肥胖的动物模型中,长链 ω-3 多不饱和脂肪酸(ω-3PUFA)补充剂一直被证明可以改善胰岛素敏感性。但在肥胖的胰岛素抵抗(IR)受试者的人体研究中,并非总是如此。
我们研究了高剂量 ω-3PUFA 补充剂是否能在肥胖的 IR 受试者中改善 3 个月的胰岛素敏感性和脂肪组织(AT)炎症。
13 名受试者(BMI=39.3±1.6kg/m)在接受 3 个月 ω-3PUFA(DHA 和 EPA,4g/天)补充前后进行了 80mU/m·min 正糖高胰岛素钳夹,并进行了皮下(Sc)AT 活检。在接受 ω-3PUFA 前后评估了细胞因子脂肪细胞因子的血浆谱。在 Sc 脂肪活检上评估了 AT 特异性炎症基因表达。对该方案中收集的脂肪活检进行了微阵列分析。
ω-3PUFA 后,棕榈酸和硬脂酸的血浆水平显著降低(P<0.05)。ω-3PUFA 后,促炎标志物和脂肪细胞因子的基因表达得到改善(P<0.05)。ω-3PUFA 后,细胞因子评估显示全身炎症减少(P<0.05)。这些变化与胰岛素刺激的葡萄糖摄取增加 25%相关(4.7±0.6mg/kg ffm·min 与 5.9±0.9mg/kg ffm·min),尽管体重没有变化。微阵列分析确定了 53 个探针集在接受 ω-3PUFA 后显著改变,载脂蛋白 E(APOE)是上调最明显的基因之一。
高剂量长链 ω-3PUFA 补充剂可调节血浆脂肪酸谱、AT 和全身炎症的显著变化。这些发现与胰岛素刺激的葡萄糖摄取的显著改善有关。Sc 脂肪活检的无偏微阵列分析确定 APOE 是 ω-3PUFA 补充后差异调节基因之一。我们推测 ω-3PUFA 增加了巨噬细胞衍生的 APOE mRNA 水平,具有抗炎作用。